|4.||Septic Shock (Toxic Shock Syndrome)
|1.||Pyörälä, Satu: 9 articles (08/2014 - 06/2006)|
|2.||Taponen, Suvi: 8 articles (08/2014 - 06/2006)|
|3.||Pyörälä, S: 8 articles (08/2012 - 03/2001)|
|4.||Schwarz, Stefan: 7 articles (07/2014 - 05/2006)|
|5.||Lacasse, P: 6 articles (06/2007 - 03/2002)|
|6.||Zhao, Xin: 5 articles (01/2015 - 01/2009)|
|7.||Calvinho, L F: 5 articles (12/2014 - 01/2000)|
|8.||Stephan, R: 5 articles (06/2013 - 02/2003)|
|9.||Simojoki, Heli: 4 articles (08/2014 - 06/2006)|
|10.||Duda, Katarzyna A: 4 articles (05/2014 - 06/2011)|
|1.||Anti-Bacterial Agents (Antibiotics)IBA
04/01/2013 - "This medicine may be an effective first line treatment for sub-clinical bovine mastitis, reducing the need for antibiotics. "
04/16/2008 - "Staphylococcus aureus is one of the main etiological agents of bovine mastitis; however, antibiotics that are effective against bovine strains of S. "
04/01/2009 - "Results of this study suggest that TC has the potential to be evaluated as an alternative or adjunct to antibiotics as intramammary infusion to treat bovine mastitis."
02/01/2009 - "This is a preliminary trial indicated beneficial effect of the herb against bovine mastitis it can be developed as an alternative therapy where the use of antibiotics is normally restricted."
08/01/2008 - "In the accompanying article, we demonstrated that a live culture of Lactococcus lactis compares favourably with antibiotics for treatment of bovine mastitis in two initial field trials. "
|2.||Penicillins (Penicillin)FDA Link
06/17/1989 - "An open, block randomised multi-centre clinical trial was performed in Norway during 1985 to 1987 to compare the therapeutic efficacy of three antibiotic regimens against clinical bovine mastitis caused by penicillin-sensitive bacteria. "
11/01/1972 - "[Studies on the treatment of subclinical bovine mastitis with isoxazolyl-penicillins in the dry period. "
06/01/2013 - "Function impairing mutations in blaZ and blaR genes of penicillin susceptible Staphylococcus aureus strains isolated from bovine mastitis."
03/01/2010 - "In parallel, independent isolates from bovine mastitis with different geographical origins (France, Holland, and Switzerland) and presenting a decreased susceptibility to penicillin were characterized. "
01/01/2000 - "Ten penicillin-resistant and -susceptible staphylococci, isolated from bovine mastitis milk, were studied for the presence of genes that are, or may be, involved in resistance against penicillin. "
|3.||Penicillin G (Benzylpenicillin)FDA LinkGeneric
03/20/2005 - "Resistance of Staphylococcus aureus to penicillin G is common among isolates from bovine mastitis. "
12/01/1992 - "Comparison of penicillin-G susceptibility testing methods of staphylococci isolated from bovine mastitis."
03/01/2010 - "Streptococcus uberis is an environmental pathogen commonly causing bovine mastitis, an infection that is generally treated with penicillin G. "
01/01/2012 - "Penethamate (PNT) is a diethylaminoethyl ester prodrug of benzylpenicillin used to treat bovine mastitis via the intramuscular route. "
06/01/2007 - "The efficacy of intramammary (IM) treatments containing penicillin G (PG) alone or a combination of PG and bovine lactoferrin (bLF) was evaluated using a model of experimentally induced chronic bovine mastitis caused by a clinical isolate of Staphylococcus aureus highly resistant to beta-lactam antibiotics. "
|4.||Cloxacillin (Tegopen)FDA Link
05/01/1983 - "Twenty-four isolates of Staphylococcus aureus from naturally occurring cases of bovine mastitis were examined in vitro for resistance to cloxacillin. "
07/01/1969 - "Cloxacillin mastitis ointment in the treatment of bovine mastitis."
04/01/1996 - "Florfenicol did not offer any advantage over cloxacillin in efficacy against bovine mastitis. "
04/01/1996 - "Florfenicol and cloxacillin did not differ significantly in efficacy versus clinical (n = 85) or subclinical (n = 71) bovine mastitis, or for any etiologic agent (X2). "
05/01/1983 - "Penicillin (cloxacillin)-tolerant Staphylococcus aureus from bovine mastitis: identification and lack of correlation between tolerance in vitro and response to therapy in vivo."
08/01/1990 - "Efficacy of chlorhexidine as a postmilking teat disinfectant for the prevention of bovine mastitis during lactation."
01/29/2003 - "A residue method was developed as part of a pharmacokinetics study to determine the elimination of chlorhexidine in raw milk after intramammary infusion into dairy cows affected with bovine mastitis. "
11/01/1995 - "Efficacy of a barrier teat dip containing .55% chlorhexidine for prevention of bovine mastitis."
|6.||diazenedicarboxylic acid bis(N'-methylpiperazide)IBA
04/17/2015 - "In the present study, partial 16S rRNA sequencing was used for the species identification of coagulase-positive and coagulase-negative staphylococci isolated from bovine mastitis. "
02/24/2012 - "Although many studies report coagulase-negative staphylococci (CNS) as the predominant cause of subclinical bovine mastitis, their epidemiology is poorly understood. "
08/01/2010 - "A partially purified form of lacticin NK34 (a Lactococcus lactis product isolated from the Korean fermented fish jeotgal) was tested to determine its antimicrobial effects against Staphylococcus aureus (n=20) and coagulase-negative Staphylococcus (CNS, n=20) strains isolated from the raw milk of cows with subclinical bovine mastitis in the present study. "
03/20/2005 - "In the present study, 188 coagulase-negative Staphylococcus (CNS) strains were isolated from bovine mastitis cases from 56 different Brazilian dairy herds, located in the Southeast region of the country, and were tested for antimicrobial substance production. "
04/01/1995 - "This study was conducted to investigate polymorphism of the coagulase gene of Staphylococcus aureus causing bovine mastitis. "
|8.||Anti-Infective Agents (Microbicides)IBA
02/01/2014 - "The strain and its bacteriocin are candidates to be included in a beneficial product to prevent bovine mastitis as an alternative to antimicrobial agents. "
01/01/2014 - "This is the first report to describe the MIC of major antimicrobial agents for Mycoplasma species isolated from bovine mastitis in Japan."
09/01/2013 - "Susceptibility to antimicrobial agents among bovine mastitis pathogens isolated from North American dairy cattle, 2002-2010."
06/01/2013 - "Antimicrobial agents were selected mainly based on their relevance to the treatment of bovine mastitis in Switzerland. "
02/01/2011 - "A total of 402 Staphylococcus aureus isolates from bovine mastitis milk collected during 2003-2009 in Korea were tested for susceptibility to 20 antimicrobial agents. "
05/01/2009 - "In the present study, adhesion, invasion and intracellular replication of twenty-two CNS strains isolated from bovine mastitis and the effect of bovine lactoferrin (bLf) on the internalization were studied in vitro in a bovine mammary epithelial (BME) cell model. "
03/01/1999 - "coli strains that were isolated from cases of bovine mastitis was determined in timekill studies in the presence of bovine lactoferrin. "
10/01/1976 - "Bovine apo-lactoferrin (apo-Lf) was added to in vitro cultures of eight strains of coliform bacteria associated with bovine mastitis. "
01/01/2007 - "Antibacterial activity of bovine lactoferrin hydrolysates (LFH) on microorganisms isolated from bovine mastitis, and superoxide (O(2)(-)) production of bovine neutrophils were evaluated. "
05/01/2002 - "Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis."
|10.||Cefoperazone (Cefoperazone Sodium)FDA Link
07/01/1985 - "A field trial was designed to investigate the efficacy of a single intramammary infusion of cefoperazone in the treatment of clinical bovine mastitis. "
07/16/2014 - "The third generation cephalosporin cefoperazone is commonly used for bovine mastitis therapy. "
05/25/2012 - "A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens."
05/25/2012 - "The aim of this study was to provide a proposal for clinical breakpoints of cefoperazone which are applicable to Staphylococcus aureus, coagulase-negative staphylococci, Escherichia coli, Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis from cases of bovine mastitis and better reflect the situation in the bovine udder than breakpoints adopted from human medicine. "
03/01/1969 - "Ultrasonic therapy for bovine mastitis."
12/01/2011 - "The interest in establishing biomarkers of the host and pathogen responses during bovine mastitis stems largely from the need to better characterize mechanisms of the disease, to identify reliable biomarkers for use as measures of early detection and drug efficacy, and to uncover potentially novel targets for the development of alternative therapeutics. "